Evidence map›Paper›PMID 37995135›Full record

ReviewDrug and alcohol review2024

Epidemiology of acute infections in people who inject drugs in Australia.

Lucy O Attwood, Daniel O'Keefe, Peter Higgs, Olga Vujovic, Joseph S Doyle, Andrew J Stewardson

Open access · hybridAbstract readReview
In one paragraph

Review in Drug and alcohol review, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lucy O AttwoodDepartment of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia.ORCID 0000-0003-0447-7917
Daniel O'KeefeBurnet Institute, Melbourne, Australia.
Peter HiggsBurnet Institute, Melbourne, Australia.ORCID 0000-0002-5587-5379
Olga VujovicDepartment of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia.
Joseph S DoyleDepartment of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia.
Andrew J StewardsonDepartment of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia.
Burnet Institute · AUThe Alfred Hospital · AU

Funding

National Health and Medical Research Council GNT1141398National Health and Medical Research Council GNT1166499National Health and Medical Research Council GNT2002670
6 · The paper itself

Abstract

issuesPeople who inject drugs are at risk of acute infections, such as skin and soft tissue infections, infective endocarditis, bone and joint infections and bloodstream infections. There has been an increase in these infections in people who inject drugs internationally over the past 10 years. However, the local data regarding acute infections in Australia has not been well described. APPROACH: We review the epidemiology of acute infections and associated morbidity and mortality amongst people who inject drugs in Australia. We summarise risk factors for these infections, including the concurrent social and psychological determinants of health. KEY

findingsThe proportion of people who report having injected drugs in the prior 12 months in Australia has decreased over the past 18 years. However, there has been an increase in the burden of acute infections in this population. This increase is driven largely by skin and soft tissue infections. People who inject drugs often have multiple conflicting priorities that can delay engagement in care. IMPLICATIONS: Acute infections in people who inject drugs are associated with significant morbidity and mortality. Acute infections contribute to significant bed days, surgical requirements and health-care costs in Australia. The increase in these infections is likely due to a complex interplay of microbiological, individual, social and environmental factors.

conclusionAcute infections in people who inject drugs in Australia represent a significant burden to both patients and health-care systems. Flexible health-care models, such as low-threshold wound clinics, would help directly target, and address early interventions, for these infections.

Indexed as

Drug UsersSoft Tissue InfectionsSubstance Abuse, IntravenousAustraliaHumansRisk Factorsepidemiologyhealth systemsinjecting drug usesepsisskin and soft tissue infections

Identifiers

PMID37995135
PMCPMC10952783
OpenAlexW4388982241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.